A Cost-Effectiveness Study of Sequential Therapy Using Levofloxacin Versus Cefuroxime in the Treatment of Moderate Risk Community-Acquired Pneumonia (ATS III) in Adults. Acta Med Philipp 2009, 43 (3). https://doi.org/10.47895/amp.v43i3.2677.